Varicella Zoster Virus Infection: Molecular Insights, Clinical Spectrum, and Advances in the Prevention and Management of Chickenpox and Shingles

The Varicella Zoster Virus (VZV), a member of the Herpesviridae family, is a highly ubiquitous and neurotropic human pathogen responsible for two distinct clinical entities: varicella (chickenpox) and herpes zoster (shingles). Primary infection, typically occurring in childhood, results in the widespread vesicular rash of varicella, a disease characterized by fever and malaise. Following resolution, VZV establishes lifelong latency in cranial nerve and dorsal root ganglia. Reactivation, often decades later due to waning cell-mediated immunity, manifests as herpes zoster—a painful, dermatomal vesicular eruption. A significant complication, postherpetic neuralgia (PHN), can cause debilitating chronic pain. VZV is a double-stranded DNA virus with a complex structure, featuring an icosahedral capsid, a protein tegument, and a host-derived lipid envelope studded with essential glycoproteins. Its transmission occurs primarily via respiratory droplets and direct contact with vesicular fluid. Diagnosis is largely clinical but can be confirmed through Polymerase Chain Reaction (PCR), which is the gold standard, Direct Fluorescent Antibody (DFA) testing, or viral culture. Antiviral therapy, including acyclovir, valacyclovir, and famciclovir, is effective in reducing the severity and duration of symptoms if initiated early. Prevention has been revolutionized by the introduction of live-attenuated vaccines for both varicella (Varivax®) and herpes zoster (Zostavax®, and the more effective adjuvanted subunit vaccine Shingrix®). Despite these advances, VZV remains a significant public health concern, particularly for immunocompromised individuals, the elderly, and in regions with low vaccination coverage. This review provides a comprehensive overview of VZV, encompassing its virology, pathogenesis, clinical spectrum, diagnostic methods, treatment strategies, and preventive measures, highlighting the ongoing challenges and future directions in managing this pervasive pathogen.